Ibrutinib Capsules.

Ibrutinib capsules are a related drug for the treatment of blood lymphomas. The main indications are:
This product is suitable for the treatment of patients with mantle cell lymphoma who have received at least one previous treatment.
This product is suitable for the treatment of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
This product is suitable for the treatment of patients with Waldenstrom’s macroglobulinemia who have received at least one previous treatment, or the first-line treatment of patients with Waldenstrom’s macroglobulinemia who are not suitable for chemoimmunotherapy.
This product is used in combination with rituximab for the treatment of patients with Waldenstrom’s macroglobulinemia.